YEAR in REVIEW: 2012 in the Arts
YEAR IN REVIEW: 2012 in the arts
Filed under: drug treatment news 2012
His self-effacing rhythmic treatment of topics including a satirical look at popularity points to the inevitable variations inherent in the mainstream appeal of the lyrical genre. "I don't drink, I don't smoke and you'll never hear drug references in …
Read more on The Hour
Back to Neutral on Bayer – Analyst Blog
Filed under: drug treatment news 2012
We are also positive on the European approval of eye-drug Eylea for treating patients suffering from neovascular (wet) age-related macular degeneration (wet AMD). Bayer is also seeking to expand the label of Eylea … In August 2012, Bayer and partner …
Read more on NASDAQ
2012: Sweeping Advances Made In MS Research
Filed under: drug treatment news 2012
Supporting a syndicate formed in the United Kingdom to conduct innovative clinical trials of neuroprotective drugs in secondary-progressive MS. New projects focusing on discovering "biomarkers" to aid better … Aubagio is the second oral disease …
Read more on The Herald | HeraldOnline.com
Diuretic Drug Offers Latest Hope for Autism Treatment
Filed under: drug treatment news 2012
… for Autism Treatment. by Greg Miller on 11 December 2012, 4:00 AM | … Bumetanide may enhance the inhibitory effects of GABA, and the drug has been used safely as a diuretic to treat a wide range of heart, lung, and kidney conditions. In the new …
Read more on Science AAAS